“We hope they will respond and we will get the results that will allow us to treat a much larger population,” Gaylis said. If the drug proves successful in reducing symptoms, Gaylis will request it for those who received the placebo. “In some people, COVID goes anywhere in the body — the brain, joints, muscles, heart … it’s got its own GPS. What’s so crazy is everyone who is a long-hauler presents differently.”